{"id":29016,"date":"2026-04-05T19:37:56","date_gmt":"2026-04-05T19:37:56","guid":{"rendered":"https:\/\/www.medicalbillersandcoders.com\/blog\/?post_type=wpseo_locations&p=29016"},"modified":"2026-04-05T19:37:56","modified_gmt":"2026-04-05T19:37:56","slug":"fix-lcd-ma-auth-eeg-emg-denials-in-california","status":"publish","type":"wpseo_locations","link":"https:\/\/www.medicalbillersandcoders.com\/blog\/locations\/fix-lcd-ma-auth-eeg-emg-denials-in-california\/","title":{"rendered":"Fix LCD, MA Auth & EEG\/EMG Denials in California"},"content":{"rendered":"

Neurology billing services in California<\/strong>\u00a0operate under a denial environment that is more demanding than almost any other state and specialty combination. Thirty-five percent of neurology claims nationally face initial denial \u2014 and in California, where Medi-Cal, multiple Medicare Advantage plans, and aggressive commercial payers like Anthem Blue Cross, Blue Shield of California, and Kaiser Permanente each apply distinct adjudication rules for EEG, EMG, and nerve conduction studies, that figure runs higher for most practices. The problems are structural, not random: LCD documentation failures, Medicare Advantage prior authorization walls, and EEG\/EMG coding errors that accumulate silently across every billing cycle until they show up as aged A\/R that never gets reprocessed.<\/p>\n

Forty percent of denied neurology claims in California are never appealed. That is not a documentation problem or a coding problem \u2014 it is a billing workflow problem. And it is fixable.<\/p>\n

The Three Structural Denial Drivers in California Neurology Billing<\/h2>\n

California neurology practices are not losing revenue because of random billing errors. They are losing it because of three predictable, structural failure patterns that repeat on every claim cycle.\u00a0Neurology billing services<\/strong><\/a>\u00a0that understand these patterns can fix them at the workflow level \u2014 before claims are submitted, not after they deny.<\/p>\n

1. LCD L34594 documentation failures \u2014 EEG, EMG, and NCS<\/h3>\n

CMS LCD L34594 \u2014 Nerve Conduction Studies and Electromyography \u2014 sets explicit documentation requirements for the highest-volume diagnostic procedures in neurology. The patient record must contain: the reason for referral, a clear diagnostic impression, and actual numeric data \u2014 latency, amplitude, and conduction velocity \u2014 presented in tabular format. A narrative summary of findings does not satisfy LCD L34594. A clinical note that says “nerve conduction studies performed with abnormal findings suggesting peripheral neuropathy” will deny. A tabular report with individual nerve values, normal reference ranges, and a physician interpretation that maps the findings to the clinical question will not.<\/p>\n

In California, this matters more than in most states because Medicare and Medicare Advantage patients represent a disproportionate share of neurology volume \u2014 and LCD L34594 applies to every Medicare and Medicare Advantage claim for NCS and EMG. Practices where the documentation workflow was built around narrative clinical notes rather than structured neurodiagnostic reports are generating LCD-based denials on every qualifying encounter.<\/p>\n

\n

EEG-specific LCD requirement:<\/strong>\u00a0Routine EEG claims (CPT 95816) require a signed physician interpretation report \u2014 not a brief addendum to the encounter note. Long-term EEG monitoring codes (95700\u201395726) require documented start and stop times for each recording session. Missing either element produces an automatic denial that most billing teams categorize as a “documentation request” and leave in an unresolved queue.<\/p>\n<\/div>\n

2. Medicare Advantage prior authorization \u2014 California’s MA landscape<\/h3>\n

California has one of the highest Medicare Advantage enrollment rates in the country. Humana, Anthem Blue Cross MA, Blue Shield Promise, and Kaiser Senior Advantage each apply distinct prior authorization requirements for neurology services \u2014 and those requirements are not aligned with Medicare fee-for-service LCD criteria. A neurological study that is covered under traditional Medicare LCD without prior authorization may require pre-approval under a California Medicare Advantage plan. The 2026 CMS rules now require MA plans to respond to standard PA requests within 7 days and urgent requests within 72 hours \u2014 but the submission must include complete documentation to be adjudicated within that window. Incomplete PA submissions are returned rather than denied, resetting the clock and delaying care and reimbursement.<\/p>\n

California MA payers that California\u00a0neurology billing services<\/strong>\u00a0must navigate with plan-specific PA protocols:<\/p>\n\n\n\n\n\n\n\n\n
California MA Plan<\/strong><\/td>\nScrutiny<\/strong><\/td>\nKey neurology PA requirement<\/strong><\/td>\n<\/tr>\n
Anthem Blue Cross MA<\/strong><\/td>\nVery high<\/span><\/td>\nRequires PA for long-term EEG monitoring (95700\u201395726 series) and all NCS studies beyond the initial diagnostic workup. Clinical notes must reference failed response to empirical treatment before PA approval for repeat NCS. Appeals require peer-to-peer within 14 days of denial.<\/td>\n<\/tr>\n
Blue Shield Promise (Medi-Cal MA)<\/strong><\/td>\nVery high<\/span><\/td>\nRequires separate PA for EEG interpretation component (Modifier 26) when performed at a facility. PA for EMG and NCS must be obtained before the procedure date \u2014 retroactive authorization is not available. 90-day timely filing window from date of service.<\/td>\n<\/tr>\n
Kaiser Senior Advantage<\/strong><\/td>\nIn-network only<\/span><\/td>\nKaiser neurology claims are payable only for Kaiser-affiliated neurologists. Out-of-network neurology services require prior approval for urgently referred conditions \u2014 not granted retroactively. Referral authorization must be in the chart before EMG\/EEG is performed.<\/td>\n<\/tr>\n
Humana (California)<\/strong><\/td>\nHigh<\/span><\/td>\nPA required for all advanced neurological imaging (MRI brain, PET) and infusion therapies. EEG and EMG do not routinely require PA but face frequent medical necessity post-pay audits \u2014 requiring LCD-compliant documentation on every claim regardless of whether PA was obtained.<\/td>\n<\/tr>\n
UnitedHealthcare MA (California)<\/strong><\/td>\nHigh<\/span><\/td>\nApplies NCCI bundling edits that deny same-day EMG and NCS without Modifier 59. PA required for neurostimulator implant services and long-term monitoring. Claims without numeric tabular NCS data in the attached documentation receive medical necessity denials regardless of PA status.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

3. EEG and EMG coding errors \u2014 the silent revenue leak<\/h3>\n

EEG and EMG coding in neurology is CPT-unit based \u2014 and undercounting or overcounting units is the most common coding error in the specialty. NCS claims (CPT 95907\u201395913) are billed by the number of nerves tested. EMG claims (CPT 95860\u201395872) are billed by the number of muscles and limbs tested. A study that tests 8 nerves should bill CPT 95911 \u2014 not 95908 (6\u20137 nerves) or 95913 (13+ nerves). Undercounting understates the work performed and leaves revenue uncollected. Overcounting triggers audit flags that produce recoupment demands months after payment.<\/p>\n

EEG billing compounds this because routine EEG (95816), EEG with sleep (95819), and long-term monitoring codes (95700\u201395726) are selected based on study type, duration, and monitoring parameters \u2014 not on the provider’s clinical impression. A routine 45-minute EEG that includes sleep states should bill 95819, not 95816. The code selection must match the technologist’s report parameters, not the ordering neurologist’s general description.<\/p>\n

\n

New in 2026 \u2014 MS code deletion causing mass denials.<\/strong>\u00a0ICD-10 code G35 (Multiple Sclerosis, unspecified) was deleted effective October 1, 2025. Any claim with a date of service on or after October 1, 2025 that uses G35 is automatically rejected as an invalid code. The replacement codes require documentation of both the MS subtype (relapsing-remitting, secondary progressive, primary progressive) and the activity status \u2014 information the prior G35 umbrella code did not require. California neurology practices with MS patients on ongoing monitoring, disease-modifying therapies, or Botox treatment plans must update every standing order and clinical template to the new MS-specific ICD-10 codes.<\/p>\n<\/div>\n

California-Specific Billing Complexity in Neurology<\/h2>\n

Beyond the three structural denial drivers, California adds layers of state-specific billing complexity that require\u00a0neurology billing services in California<\/strong><\/a>\u00a0to maintain protocols that national billing generalists do not carry:<\/p>\n